Related references
Note: Only part of the references are listed.Immunomodulation by targeted anticancer agents
Giulia Petroni et al.
CANCER CELL (2021)
Modulation of intratumoural myeloid cells, the hallmark of the anti-tumour efficacy induced by a triple combination: tumour-associated peptide, TLR-3 ligand and α-PD-1
Sara Zalba et al.
BRITISH JOURNAL OF CANCER (2021)
Intratumoral virotherapy with 4-1BBL armed modified vaccinia Ankara eradicates solid tumors and promotes protective immune memory
Maria Hinterberger et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Immunological configuration of ovarian carcinoma: features and impact on disease outcome
Jitka Fucikova et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
An Efficient Prognostic Immune Scoring System For Colorectal Cancer Patients With Peritoneal Metastasis
Yamei Zhao et al.
ONCOIMMUNOLOGY (2021)
Prognostic image-based quantification of CD8CD103 T cell subsets in high-grade serous ovarian cancer patients
S. T. Paijens et al.
ONCOIMMUNOLOGY (2021)
Cellular cytotoxicity is a form of immunogenic cell death
Luna Minute et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
Patrick A. Ott et al.
CELL (2020)
Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox
Phillip R. Pittman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodies
Jose Medina-Echeverz et al.
NATURE COMMUNICATIONS (2019)
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Zong Sheng Guo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Sipuleucel-T for the treatment of prostate cancer: novel insights and future directions
Catherine E. Handy et al.
FUTURE ONCOLOGY (2018)
CD40L Expression Allows CD8+ T Cells to Promote Their Own Expansion and Differentiation through Dendritic Cells
Neil Q. Tay et al.
FRONTIERS IN IMMUNOLOGY (2017)
Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus
Emma Eriksson et al.
CLINICAL CANCER RESEARCH (2017)
Complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: Risk factors for ICU admission and morbidity prognostic score
Sylvain Malfroy et al.
SURGICAL ONCOLOGY-OXFORD (2016)
Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb
Bettina Weigelin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
Trimmomatic: a flexible trimmer for Illumina sequence data
Anthony M. Bolger et al.
BIOINFORMATICS (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Peritoneal carcinomatosis
Federico Coccolini et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Molecular signatures database (MSigDB) 3.0
Arthur Liberzon et al.
BIOINFORMATICS (2011)
Adjuvant Combination and Antigen Targeting as a Strategy to Induce Polyfunctional and High-Avidity T-Cell Responses against Poorly Immunogenic Tumors
Fernando Aranda et al.
CANCER RESEARCH (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)